Agenda

Haemato-oncology

21 October 2024 • 16:00 -17:20 • London Hall

Changes to medicines programmes, including optimization of guidelines for the treatment of chronic lymphocytic leukemia and multiple myeloma
Access to treatment for patients with transfusion-dependent, low-risk myelodysplastic neoplasms
CAR-T in the treatment of plasmocytic myeloma and lymphoma

Back

You watching archival version of Forum.

What you can do: